Nancy C. Andrews's most recent trade in Charles River Laboratories International Inc. was a trade of 2,076 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on May 21, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Charles River Labs | Nancy C. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 2,076 | 2,076 | - | - | Stock Options (Right to Buy) | |
Charles River Labs | Nancy C. Andrews | Director | Grant, award, or other acquisition of securities at price $ 134.98 per share. | 21 May 2025 | 946 | 3,964 (0%) | 0% | 135.0 | 127,691 | Common Stock |
Charles River Labs | Nancy C. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 1,311 | 1,311 | - | - | Stock Options (Right to Buy) | |
Charles River Labs | Nancy C. Andrews | Director | Grant, award, or other acquisition of securities at price $ 228.41 per share. | 13 May 2024 | 559 | 3,018 (0%) | 0% | 228.4 | 127,681 | Common Stock |
Charles River Labs | Nancy C. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 1,669 | 1,669 | - | - | Stock Options (Right to Buy) | |
Charles River Labs | Nancy C. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 664 | 2,459 (0%) | 0% | 0 | Common Stock | |
Charles River Labs | Nancy C. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 1,582 | 1,582 | - | - | Stock Options (Right to Buy) | |
Charles River Labs | Nancy C. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 575 | 1,795 (0%) | 0% | 0 | Common Stock | |
Charles River Labs | Nancy C. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2021 | 1,151 | 1,151 | - | - | Stock Options (Right to Buy) | |
Charles River Labs | Nancy C. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2021 | 355 | 1,220 (0%) | 0% | 0 | Common Stock |